Notizia

(Reuters) -Eli Lilly and Co on Wednesday appointed a new chief for its diabetes and obesity unit in a string of leadership changes ahead of a key regulatory decision on the use of its potential blockbuster drug Mounjaro as a weight-loss treatment.

(Reuters) -Eli Lilly and Co said on Wednesday that the head of its diabetes and obesity division, Mike Mason, will retire by the end of the year after more than three decades with the drugmaker.

Hong Kong-based Affinity Equity Partners has paused plans to launch a so-called continuation fund enabling itself and its investors to sell down their shares in companies because of unfavourable market conditions, said two people with knowledge of the matter.

WELLINGTON (Reuters) -New Zealand's central bank held rates steady on Wednesday as policymakers were more confident that past hikes were working to bring down inflation as desired, sending the local dollar skidding as markets pared bets of any further tightening.

A federal judge on Tuesday refused to let the U.S. Securities and Exchange Commission appeal her recent decision involving Ripple Labs, a ruling that has been seen as a major defeat for the regulator in its effort to police cryptocurrency markets.

New Zealand's central bank held the cash rate steady at 5.5% on Wednesday, as policymakers reiterated that past tightening had helped constrain spending and temper inflation as required.

A look at the day ahead in Asian markets from Jamie McGeever, financial markets columnist.

ORLANDO, Florida (Reuters) -Stick it out, double down, or cut your losses?